Sponsored Content

PharmaLinea's product awarded for innovation in bone and joint health

>Your< Arthro Ease Capsules received the Annual Bone and Joint Health Award at the Functional Foods for Wellness Summit 2025

The Functional Foods for Wellness Industry Awards (FFWS Awards) aim to recognize products that significantly contribute to nutraceutical industry development. At the 2025 FFWS Awards, PharmaLinea's >Your< Arthro Ease Capsules were awarded for innovation in bone & joint and women’s health.

FFWS Awards showcase enterprises and products in the Asia-Pacific region that demonstrate innovation, outstanding achievements, or make significant contributions to the development of the functional food, dietary supplements, and nutrition fields. This recognition of PharmaLinea’s solution for joint pain relief and ease of movement underscores the growing market demand for clinically validated, next-generation solutions in joint health.

A growing need for next-generation solutions in the joint health supplements space

While joint health is a well-established supplement category, the market is evolving with new advanced and clinically validated ingredients and formulations. Consumers increasingly demand products with proven efficacy, as many traditional solutions fail to meet expectations.

“Many consumers believe that currently available supplements for joint health lack efficacy,“ explained PharmaLinea’s Marketing Director, Matevž Ambrožič. “Next-generation formulations and products addressing joint pain, such as Haleon’s PanaNatra, are seeing high commercial success, signalling a shift in consumer preferences..“

>Your< Arthro Ease Capsules

Designed for multimodal tissue regeneration, >Your< Arthro Ease Capsules deliver high efficacy at a low dose.

“Our formulation is based on Qllagen®, PharmaLinea’s branded, high-quality type II undenatured collagen,“ stated Veronika Pipan, Head of Scientific Support at PharmaLinea. “With 4 clinical studies backing its efficacy, the product has demonstrated a significantly higher pain reduction and joint health functionality restoration than classic joint health products or NSAIDs.“

The growing stack of clinical data on >Your< Arthro Ease Capsules includes:

§  a multicenter, double-blind, placebo-controlled, randomized study in patients with stage 2–3 primary osteoarthritis of the knee joint

§  an open randomized prospective study that compared >Your< Arthro Ease Capsules with active control in patients with osteoarthritis with stage 1–3 knee joint damage

§  an open randomized observational study in patients with chronic nonspecific pain in the lower back

§  a clinical study that evaluated the efficacy of combined therapy using NSAIDs and >Your< Arthro Ease Capsules in subjects with shoulder osteoarthritis in an outpatient setting